No! Why drop the gum - the entree into pharma - when it is being paid for with current revenues? They should file the IND and start Phase I and then partner with a pharma company that sees the future. As much as they are killing it with retail, the drug is worth far more!!
I've been in pharma for years, and while the drug would be more valuable if it made it to phase II, that gets pricey, so I expect a partnership before that time.